查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
肽治疗药物市场 - 按类型（品牌、非专利）、按应用（代谢、癌症、心血管、胃肠道）、按给药途径（肠外、口服）、按销售渠道（医院、零售） - 2023 年至 2032 年全球预测
市场调查报告书
商品编码
1309835

肽治疗药物市场 - 按类型（品牌、非专利）、按应用（代谢、癌症、心血管、胃肠道）、按给药途径（肠外、口服）、按销售渠道（医院、零售） - 2023 年至 2032 年全球预测

Peptide Therapeutics Market - By Type (Branded, Generic), By Application (Metabolic, Cancer, Cardiovascular, Gastrointestinal), By Route of Administration (Parenteral, Oral), By Distribution Channel (Hospital, Retail)- Global Forecast 2023 to 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 240 Pages | 商品交期: 2-3个工作天内

价格

全球多肽治疗药物市场将在 2023-2032 年间呈现指数级增长。

由于糖尿病、癌症和心血管疾病等慢性疾病的负担日益加重，人们对个性化和靶向治疗方案的需求不断增加，这将在未来十年内刺激该行业的收入流。据世界卫生组织统计，全球约有 4.22 亿人患有糖尿病，每年有 150 万人因此丧生。

多肽疗法具有高特异性、低毒性和良好的生物相容性等优势，是药物开发的理想选择。多肽合成技术和给药系统的进步提高了多肽药物的稳定性、生物利用度和半衰期，进一步推动了多肽药物的应用。此外，随着学术机构与制药公司之间合作的不断增加，研发活动也在持续进行，这将促进新型多肽疗法的发现，推动市场增长。

多肽疗法的总体市场份额根据类型、应用、给药途径、销售渠道和地区进行分类。

就类型而言，到 2032 年，非专利肽疗法行业将取得显著增长。多肽原研药的专利到期为非专利药开辟了市场，提供了具有成本效益的替代品。慢性疾病负担日益加重，需要经济实惠的治疗方案，这进一步刺激了对非专利多肽疗法的需求。此外，促进使用仿制药的监管措施也鼓励了全球医疗系统采用仿制药，这将有助于在未来几年扩大细分市场的收益。

在应用方面，癌症领域的多肽疗法市场规模将在 2023-2032 年间大幅增长。由于多肽具有靶向和个性化治疗的潜力，癌症应用领域对多肽治疗剂的需求不断增加。多肽可专门针对癌细胞，同时保护健康细胞，减少副作用。此外，基于多肽的免疫疗法（如免疫检查点抑制剂）在增强机体对癌细胞的免疫反应方面也显示出良好的效果。

根据给药途径，到 2032 年，口服部分将占据多肽疗法行业收入的显著份额。口服给药是一种非侵入性的给药方式，对患者来说更方便，能提高依从性和治疗的坚持性。制剂技术的进步，如多肽稳定剂和酶抑制剂的使用，提高了多肽药物的口服生物利用度和稳定性。此外，与注射或输液等其他途径相比，口服给药具有节约成本的潜力，从而进一步促进了该细分市场的发展。

就地区而言，亚太地区多肽治疗市场在 2023 年至 2032 年期间将呈现可观的增长率。癌症、糖尿病和心血管疾病等慢性疾病的发病率不断上升，对有效的治疗方案产生了巨大需求。医疗保健支出的增加、中产阶级人口的扩大以及医疗保健基础设施的改善进一步促进了需求的增长。此外，中国、日本和韩国等国研发能力的提高促进了创新，基于多肽的疗法的开发将推动该地区市场的增长。

目 录

第 1 章：方法与范围

第2章：执行摘要

第3章：多肽治疗药物市场洞察

  • 2018-2032年行业格局
  • 行业影响因素
    • 增长驱动力
      • 癌症发病率上升
      • 代谢紊乱发病率上升
      • 新型药物研发投资不断增加
      • 多肽疗法的技术进步
    • 行业陷阱与挑战
      • 药品审批监管要求严格
      • 药物开发成本高昂
  • 增长潜力分析
    • 按类型
    • 按应用
    • 按给药途径
    • 按生产商类型
    • 按合成技术
    • 按销售渠道
  • COVID-19 的影响分析
  • 监管格局
  • 波特分析
  • PESTEL 分析

第 4 章：2022 年竞争格局

  • 简介
  • 2022 年公司矩阵分析
  • 2022 年全球公司市场份额分析
  • 2022 年竞争定位矩阵
  • 2022 年战略仪表板

第 5 章：多肽治疗药物市场估计与预测：按类型划分

  • 按类型分類的主要趋势
  • 品牌多肽
  • 非专利多肽

第6章：多肽治疗剂市场估计与预测：按应用分类

  • 按应用分類的主要趋势
  • 代谢紊乱
  • 癌症
  • 心血管疾病
  • 胃肠道疾病
  • 中枢神经系统疾病
  • 传染病
  • 呼吸系统疾病
  • 疼痛治疗
  • 肾脏疾病
  • 皮肤病学
  • 其他应用

第 7 章 ：多肽治疗药物市场估计与预测：按给药途径分类

  • 按给药途径分類的主要趋势
  • 肠外
  • 口服
  • 其他给药途径

第8章：肽治疗药物市场估计与预测：按制造商类型划分

  • 按生产商类型分類的主要趋势
  • 内部生产
  • 外包

第九章：多肽治疗药物市场估计与预测：按合成技术分类

  • 按合成技术分類的主要趋势
  • 液相多肽合成（LPPS）
  • 固相多肽合成（SPPS）
  • 混合技术

第10章：按销售渠道分類的多肽治疗药物市场估计与预测

  • 按销售渠道分類的主要趋势
  • 医院药房
  • 零售药店
  • 网上药店

第十一章 ：肽治疗药物市场估计与预测：按地区划分

  • 各地区主要趋势
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 瑞士
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 中东和非洲其他地区

第 12 章 ：公司简介

  • Pfizer, Inc
  • Amgen, Inc
  • Bachem Holding AG
  • Eli Lilly and Company
  • Sanofi
  • AstraZeneca plc
  • AbbVie
  • GlaxoSmithKline plc
  • Baush Health
  • Lonza Inc.
Product Code: 5635

Global Peptide Therapeutics Market will exhibit exponential growth over 2023- 2032.

Increasing demand for personalized and targeted treatment options pushed by the growing burden of chronic diseases such as diabetes, cancer, and cardiovascular disorders will stimulate industry revenue streams over the next ten years. According to WHO, diabetes affects around 422 million people worldwide and claims the lives of 1.5 million people each year.

Peptide therapeutics offer advantages like high specificity, low toxicity, and excellent biocompatibility, making them an attractive choice for drug development. Advancements in peptide synthesis technologies and drug delivery systems have improved the stability, bioavailability, and half-life of peptide drugs, further propelling their adoption. Moreover, ongoing R&D activities, in line with increasing collaborations between academic institutions and pharmaceutical companies, will fuel the discovery of novel peptide-based therapies, driving market growth.

The overall peptide therapeutics market share is categorized based on type, application, route of administration, distribution channel, and region.

Regarding the type, the generic peptide therapeutics industry will register significant gains through 2032. The expiration of patents for original peptide drugs has opened the market for generic versions, offering cost-effective alternatives. The increasing burden of chronic diseases has created a need for affordable treatment options, further stimulating the demand for generic peptide therapeutics. Besides, regulatory initiatives promoting the use of generic drugs have encouraged their adoption in healthcare systems worldwide, which will help augment segment gains over the coming years.

With respect to application, the peptide therapeutics market size from the cancer segment will grow substantially over 2023-2032. The demand for peptide therapeutics in cancer applications is increasing due to their potential for targeted and personalized treatment. Peptides can specifically target cancer cells while sparing healthy cells, reducing side effects. Additionally, peptide-based immunotherapies, such as immune checkpoint inhibitors, have shown promising results in boosting the body's immune response against cancer cells.

Based on the route of administration, the oral segment could amass a notable share of the peptide therapeutics industry revenue by 2032. Oral delivery is non-invasive and more convenient for patients, improving compliance and treatment adherence. Advances in formulation technologies, such as the use of peptide stabilizers and enzyme inhibitors, have improved the oral bioavailability and stability of peptide drugs. This apart, oral delivery offers potential cost savings compared to other routes, such as injections or infusions, further contributing to segment gains.

Regionally, the Asia Pacific peptide therapeutics market will exhibit an appreciable growth rate between 2023 and 2032. The increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders, has created a significant need for effective treatment options. Rising healthcare expenditures, expanding middle-class population, and improving healthcare infrastructure have further contributed to the increasing demand. Besides, advancements in R&D capabilities in countries like China, Japan, and South Korea have fostered innovation, and the development of peptide-based therapies will drive market growth in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates and calculations
  • 1.3 Forecast calculations
  • 1.4 Data sources
    • 1.4.1 Secondary
      • 1.4.1.1 Paid sources
      • 1.4.1.2 Public sources
    • 1.4.2 Primary

Chapter 2 Executive Summary

  • 2.1 Peptide therapeutics industry 360 degree synopsis, 2018 - 2032 (USD Billion)
    • 2.1.1 Business trends
    • 2.1.2 Type trends
    • 2.1.3 Application trends
    • 2.1.4 Route of administration trends
    • 2.1.5 Manufacturer type trends
    • 2.1.6 Synthesis technology trends
    • 2.1.7 Distribution channel trends
    • 2.1.8 Region trends

Chapter 3 Peptide Therapeutics Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Billion)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of cancer
      • 3.2.1.2 Rising incidences of metabolic disorders
      • 3.2.1.3 Increasing investments in R&D of novel drugs
      • 3.2.1.4 Technological advancement in peptide therapeutics
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulatory requirements for drug approval
      • 3.2.2.2 High cost for drug development
  • 3.3 Growth potential analysis
    • 3.3.1 By type
    • 3.3.2 By application
    • 3.3.3 By route of administration
    • 3.3.4 By manufacturer type
    • 3.3.5 By synthesis technology
    • 3.3.6 By distribution channel
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Global Company market share analysis, 2022
  • 4.4 Competitive positioning matrix, 2022
  • 4.5 Strategic dashboard, 2022

Chapter 5 Peptide Therapeutics Market Estimates and Forecast, By Type (USD Billion)

  • 5.1 Key trends, by type
  • 5.2 Branded peptides
  • 5.3 Generic peptides

Chapter 6 Peptide Therapeutics Market Estimates and Forecast, By Application (USD Billion)

  • 6.1 Key trends, by application
  • 6.2 Metabolic disorders
  • 6.3 Cancer
  • 6.4 Cardiovascular disorders
  • 6.5 Gastrointestinal disorders
  • 6.6 Central nervous system disorders
  • 6.7 Infectious diseases
  • 6.8 Respiratory disorders
  • 6.9 Pain management
  • 6.10 Renal disorders
  • 6.11 Dermatology
  • 6.12 Other applications

Chapter 7 Peptide Therapeutics Market Estimates and Forecast, By Route of Administration (USD Billion)

  • 7.1 Key trends, by route of administration
  • 7.2 Parenteral
  • 7.3 Oral
  • 7.4 Other routes of administration

Chapter 8 Peptide Therapeutics Market Estimates and Forecast, By Manufacturer Type (USD Billion)

  • 8.1 Key trends, by manufacturer type
  • 8.2 In-house
  • 8.3 Outsourced

Chapter 9 Peptide Therapeutics Market Estimates and Forecast, By Synthesis Technology (USD Billion)

  • 9.1 Key trends, by synthesis technology
  • 9.2 Liquid phase peptide synthesis (LPPS)
  • 9.3 Solid phase peptide synthesis (SPPS)
  • 9.4 Hybrid Technology

Chapter 10 Peptide Therapeutics Market Estimates and Forecast, By Distribution Channel (USD Billion)

  • 10.1 Key trends, by distribution channel
  • 10.2 Hospital pharmacies
  • 10.3 Retail pharmacies
  • 10.4 Online pharmacies

Chapter 11 Peptide Therapeutics Market Estimates and Forecast, By Region (USD Billion)

  • 11.1 Key trends, by region
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Spain
    • 11.3.5 Italy
    • 11.3.6 Switzerland
    • 11.3.7 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 South Korea
    • 11.4.6 Rest of Asia Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Rest of Latin America
  • 11.6 Middle East & Africa
    • 11.6.1 South Africa
    • 11.6.2 Saudi Arabia
    • 11.6.3 Rest of MEA

Chapter 12 Company Profiles

  • 12.1 Pfizer, Inc
  • 12.2 Amgen, Inc
  • 12.3 Bachem Holding AG
  • 12.4 Eli Lilly and Company
  • 12.5 Sanofi
  • 12.6 AstraZeneca plc
  • 12.7 AbbVie
  • 12.8 GlaxoSmithKline plc
  • 12.9 Baush Health
  • 12.10 Lonza Inc.

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by type (2022)
  • TABLE 3 Market revenue, by application (2022)
  • TABLE 4 Market revenue, by route of administration (2022)
  • TABLE 5 Market revenue, by manufacturer type (2022)
  • TABLE 6 Market revenue, by synthesis technology (2022)
  • TABLE 7 Market share, by distribution channel (2022)
  • TABLE 8 Market share, by region (2022)
  • TABLE 9 Global peptide therapeutics market size, by region, 2018 - 2022 (USD Billion)
  • TABLE 10 Global peptide therapeutics market size, by region, 2023 - 2032 (USD Billion)
  • TABLE 11 Global peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 12 Global peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 13 Global peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 14 Global peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 15 Global peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 16 Global peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 17 Global peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 18 Global peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 19 Global peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 20 Global peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 21 Global peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 22 Global peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 23 Industry impact forces
  • TABLE 24 Competitive benchmarking of major market players
  • TABLE 25 Competitive positioning matrix: Classification criteria
  • TABLE 26 Strategic outlook matrix: Classification criteria
  • TABLE 27 Branded peptides market size, 2018 - 2022 (USD Billion)
  • TABLE 28 Branded peptides market size, 2023 - 2032 (USD Billion)
  • TABLE 29 Generic peptides market size, 2018 - 2022 (USD Billion)
  • TABLE 30 Generic peptides market size, 2023 - 2032 (USD Billion)
  • TABLE 31 Metabolic disorders market size, 2018 - 2022 (USD Billion)
  • TABLE 32 Metabolic disorders market size, 2023 - 2032 (USD Billion)
  • TABLE 33 Cancer market size, 2018 - 2022 (USD Billion)
  • TABLE 34 Cancer market size, 2023 - 2032 (USD Billion)
  • TABLE 35 Cardiovascular disorders market size, 2018 - 2022 (USD Billion)
  • TABLE 36 Cardiovascular disorders market size, 2023 - 2032 (USD Billion)
  • TABLE 37 Gastrointestinal disorders market size, 2018 - 2022 (USD Billion)
  • TABLE 38 Gastrointestinal disorders market size, 2023 - 2032 (USD Billion)
  • TABLE 39 Central nervous system disorders market size, 2018 - 2022 (USD Billion)
  • TABLE 40 Central nervous system disorders market size, 2023 - 2032 (USD Billion)
  • TABLE 41 Infectious diseases market size, 2018 - 2022 (USD Billion)
  • TABLE 42 Infectious diseases market size, 2023 - 2032 (USD Billion)
  • TABLE 43 Respiratory disorders market size, 2018 - 2022 (USD Billion)
  • TABLE 44 Respiratory disorders market size, 2023 - 2032 (USD Billion)
  • TABLE 45 Pain management market size, 2018 - 2022 (USD Billion)
  • TABLE 46 Pain management market size, 2023 - 2032 (USD Billion)
  • TABLE 47 Renal disorders market size, 2018 - 2022 (USD Billion)
  • TABLE 48 Renal disorders market size, 2023 - 2032 (USD Billion)
  • TABLE 49 Dermatology market size, 2018 - 2022 (USD Billion)
  • TABLE 50 Dermatology market size, 2023 - 2032 (USD Billion)
  • TABLE 51 Other applications market size, 2018 - 2022 (USD Billion)
  • TABLE 52 Other applications market size, 2023 - 2032 (USD Billion)
  • TABLE 53 Parenteral market size, 2018 - 2022 (USD Billion)
  • TABLE 54 Parenteral market size, 2023 - 2032 (USD Billion)
  • TABLE 55 Oral market size, 2018 - 2022 (USD Billion)
  • TABLE 56 Oral market size, 2023 - 2032 (USD Billion)
  • TABLE 57 Other routes of administration market size, 2018 - 2022 (USD Billion)
  • TABLE 58 Other routes of administration market size, 2023 - 2032 (USD Billion)
  • TABLE 59 In-house market size, 2018 - 2022 (USD Billion)
  • TABLE 60 In-house market size, 2023 - 2032 (USD Billion)
  • TABLE 61 Outsourced market size, 2018 - 2022 (USD Billion)
  • TABLE 62 Outsourced market size, 2023 - 2032 (USD Billion)
  • TABLE 63 Liquid phase peptide synthesis market size, 2018 - 2022 (USD Billion)
  • TABLE 64 Liquid phase peptide synthesis market size, 2023 - 2032 (USD Billion)
  • TABLE 65 Solid phase peptide synthesis market size, 2018 - 2022 (USD Billion)
  • TABLE 66 Solid phase peptide synthesis market size, 2023 - 2032 (USD Billion)
  • TABLE 67 Hybrid technology market size, 2018 - 2022 (USD Billion)
  • TABLE 68 Hybrid technology market size, 2023 - 2032 (USD Billion)
  • TABLE 69 North America peptide therapeutics market size, by country, 2018 - 2022 (USD Billion)
  • TABLE 70 North America peptide therapeutics market size, by country, 2023 - 2032 (USD Billion)
  • TABLE 71 North America peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 72 North America peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 73 North America peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 74 North America peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 75 North America peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 76 North America peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 77 North America peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 78 North America peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 79 North America peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 80 North America peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 81 North America peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 82 North America peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 83 U.S. peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 84 U.S. peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 85 U.S. peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 86 U.S. peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 87 U.S. peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 88 U.S. peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 89 U.S. peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 90 U.S. peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 91 U.S. peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 92 U.S. peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 93 U.S. peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 94 U.S. peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 95 Canada peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 96 Canada peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 97 Canada peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 98 Canada peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 99 Canada peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 100 Canada peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 101 Canada peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 102 Canada peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 103 Canada peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 104 Canada peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 105 Canada peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 106 Canada peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 107 Europe peptide therapeutics market size, by country, 2018 - 2022 (USD Billion)
  • TABLE 108 Europe peptide therapeutics market size, by country, 2023 - 2032 (USD Billion)
  • TABLE 109 Europe peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 110 Europe peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 111 Europe peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 112 Europe peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 113 Europe peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 114 Europe peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 115 Europe peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 116 Europe peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 117 Europe peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 118 Europe peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 119 Europe peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 120 Europe peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 121 Germany peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 122 Germany peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 123 Germany peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 124 Germany peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 125 Germany peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 126 Germany peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 127 Germany peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 128 Germany peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 129 Germany peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 130 Germany peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 131 Germany peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 132 Germany peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 133 UK peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 134 UK peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 135 UK peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 136 UK peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 137 UK peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 138 UK peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 139 UK peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 140 UK peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 141 UK peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 142 UK peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 143 UK peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 144 UK peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 145 France peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 146 France peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 147 France peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 148 France peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 149 France peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 150 France peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 151 France peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 152 France peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 153 France peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 154 France peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 155 France peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 156 France peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 157 Spain peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 158 Spain peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 159 Spain peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 160 Spain peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 161 Spain peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 162 Spain peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 163 Spain peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 164 Spain peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 165 Spain peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 166 Spain peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 167 Spain peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 168 Spain peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 169 Italy peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 170 Italy peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 171 Italy peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 172 Italy peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 173 Italy peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 174 Italy peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 175 Italy peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 176 Italy peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 177 Italy peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 178 Italy peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 179 Italy peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 180 Italy peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 181 Switzerland peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 182 Switzerland peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 183 Switzerland peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 184 Switzerland peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 185 Switzerland peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 186 Switzerland peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 187 Switzerland peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 188 Switzerland peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 189 Switzerland peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 190 Switzerland peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 191 Switzerland peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 192 Switzerland peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 193 Rest of Europe peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 194 Rest of Europe peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 195 Rest of Europe peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 196 Rest of Europe peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 197 Rest of Europe peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 198 Rest of Europe peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 199 Rest of Europe peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 200 Rest of Europe peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 201 Rest of Europe peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 202 Rest of Europe peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 203 Rest of Europe peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 204 Rest of Europe peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 205 Asia Pacific peptide therapeutics market size, by country, 2018 - 2022 (USD Billion)
  • TABLE 206 Asia Pacific peptide therapeutics market size, by country, 2023 - 2032 (USD Billion)
  • TABLE 207 Asia Pacific peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 208 Asia Pacific peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 209 Asia Pacific peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 210 Asia Pacific peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 211 Asia Pacific peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 212 Asia Pacific peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 213 Asia Pacific peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 214 Asia Pacific peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 215 Asia Pacific peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 216 Asia Pacific peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 217 Asia Pacific peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 218 Asia Pacific peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 219 China peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 220 China peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 221 China peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 222 China peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 223 China peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 224 China peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 225 China peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 226 China peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 227 China peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 228 China peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 229 China peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 230 China peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 231 Japan peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 232 Japan peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 233 Japan peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 234 Japan peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 235 Japan peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 236 Japan peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 237 Japan peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 238 Japan peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 239 Japan peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 240 Japan peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 241 Japan peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 242 Japan peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 243 India peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 244 India peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 245 India peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 246 India peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 247 India peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 248 India peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 249 India peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 250 India peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 251 India peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 252 India peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 253 India peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 254 India peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 255 Australia peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 256 Australia peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 257 Australia peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 258 Australia peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 259 Australia peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 260 Australia peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 261 Australia peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 262 Australia peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 263 Australia peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 264 Australia peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 265 Australia peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 266 Australia peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 267 South Korea peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 268 South Korea peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 269 South Korea peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 270 South Korea peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 271 South Korea peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 272 South Korea peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 273 South Korea peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 274 South Korea peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 275 South Korea peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 276 South Korea peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 277 South Korea peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 278 South Korea peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 279 Rest of Asia Pacific peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 280 Rest of Asia Pacific peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 281 Rest of Asia Pacific peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 282 Rest of Asia Pacific peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 283 Rest of Asia Pacific peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 284 Rest of Asia Pacific peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 285 Rest of Asia Pacific peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 286 Rest of Asia Pacific peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 287 Rest of Asia Pacific peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 288 Rest of Asia Pacific peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 289 Rest of Asia Pacific peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 290 Rest of Asia Pacific peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 291 Latin America peptide therapeutics market size, by country, 2018 - 2022 (USD Billion)
  • TABLE 292 Latin America peptide therapeutics market size, by country, 2023 - 2032 (USD Billion)
  • TABLE 293 Latin America peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 294 Latin America peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 295 Latin America peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 296 Latin America peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 297 Latin America peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 298 Latin America peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 299 Latin America peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 300 Latin America peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 301 Latin America peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 302 Latin America peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 303 Latin America peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 304 Latin America peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 305 Brazil peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 306 Brazil peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 307 Brazil peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 308 Brazil peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 309 Brazil peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 310 Brazil peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 311 Brazil peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 312 Brazil peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 313 Brazil peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 314 Brazil peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 315 Brazil peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 316 Brazil peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 317 Mexico peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 318 Mexico peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 319 Mexico peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 320 Mexico peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 321 Mexico peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 322 Mexico peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 323 Mexico peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 324 Mexico peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 325 Mexico peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 326 Mexico peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 327 Mexico peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 328 Mexico peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 329 Rest of Latin America peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 330 Rest of Latin America peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 331 Rest of Latin America peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 332 Rest of Latin America peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 333 Rest of Latin America peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 334 Rest of Latin America peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 335 Rest of Latin America peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 336 Rest of Latin America peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 337 Rest of Latin America peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 338 Rest of Latin America peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 339 Rest of Latin America peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 340 Rest of Latin America peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 341 MEA peptide therapeutics market size, by country, 2018 - 2022 (USD Billion)
  • TABLE 342 MEA peptide therapeutics market size, by country, 2023 - 2032 (USD Billion)
  • TABLE 343 MEA peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 344 MEA peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 345 MEA peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 346 MEA peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 347 MEA peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 348 MEA peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 349 MEA peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 350 MEA peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 351 MEA peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 352 MEA peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 353 MEA peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 354 MEA peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 355 South Africa peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 356 South Africa peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 357 South Africa peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 358 South Africa peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 359 South Africa peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 360 South Africa peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 361 South Africa peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 362 South Africa peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 363 South Africa peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 364 South Africa peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 365 South Africa peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 366 South Africa peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 367 Saudi Arabia peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 368 Saudi Arabia peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 369 Saudi Arabia peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 370 Saudi Arabia peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 371 Saudi Arabia peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 372 Saudi Arabia peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 373 Saudi Arabia peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 374 Saudi Arabia peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 375 Saudi Arabia peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 376 Saudi Arabia peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 377 Saudi Arabia peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 378 Saudi Arabia peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 379 Rest of MEA peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 380 Rest of MEA peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 381 Rest of MEA peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 382 Rest of MEA peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 383 Rest of MEA peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 384 Rest of MEA peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 385 Rest of MEA peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 386 Rest of MEA peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 387 Rest of MEA peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 388 Rest of MEA peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 389 Rest of MEA peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 390 Rest of MEA peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Peptide therapeutics industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by type
  • FIG 8 Growth potential analysis, by application
  • FIG 9 Growth potential analysis, by route of administration
  • FIG 10 Growth potential analysis, by manufacturer type
  • FIG 11 Growth potential analysis, by synthesis technology
  • FIG 12 Growth potential analysis, by distribution channel
  • FIG 13 Porter's analysis
  • FIG 14 PESTEL analysis
  • FIG 15 Company matrix analysis, 2022
  • FIG 16 Global Company market share analysis, 2022
  • FIG 17 Competitive positioning matrix, 2022
  • FIG 18 Strategic dashboard, 2022